Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention

被引:6
|
作者
Hwang, In-Chang [1 ,2 ,3 ,4 ]
Kim, Chee Hae [5 ]
Kim, Jae-Young [6 ]
Choi, Hong-Mi [2 ,3 ,4 ]
Yoon, Yeonyee E. [2 ,3 ,4 ]
Cho, Goo-Yeong [2 ,3 ,4 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Div Cardiol, Bundang Hosp, 82 Gumi ro 173 Beon gil, Seongnam Si 13620, Gyeonggi Do, South Korea
[2] Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Seongnam, Gyeonggi, South Korea
[3] Seoul Natl Univ, Dept Internal Med, Div Cardiol, Bundang Hosp, Seongnam, Gyeonggi, South Korea
[4] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Vet Hlth Serv Med Ctr, Seoul, South Korea
[6] Soonchunhyang Univ, Dept Stat, Bucheon Hosp, Bucheon, Gyeonggi, South Korea
关键词
cardiovascular diseases; cardiovascular risk factors; cardiovascular risk score; primary prevention; prognosis; ASSOCIATION; VALIDATION;
D O I
10.1161/HYPERTENSIONAHA.122.20678
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
BACKGROUND:Contemporary cardiovascular primary prevention is based on the assessment of the 10-year risk of atherosclerotic cardiovascular disease (ASCVD). However, the clinical implications of temporal change in the 10-year ASCVD risk estimate ( increment 10-year ASCVD risk/year) are unknown. METHODS:A total of 211 077 participants without established ASCVD and with repetitive 10-year ASCVD risk assessment at an interval of 4 to 5 years were selected from the Korean National Health Insurance Service data. The primary end point was a composite of myocardial infarction, stroke, coronary revascularization, and all-cause death. RESULTS:ASCVD event rates were proportional to the increment 10-year ASCVD risk/year regardless of the baseline 10-year ASCVD risk. Adjusted hazard ratio for ASCVD events per 1% increase in increment 10-year ASCVD risk/year was 1.53 (95% CI, 1.44-1.63), 1.24 (95% CI, 1.15-1.32), 1.18 (95% CI, 1.13-1.23), and 1.05 (95% CI, 1.00-1.10) in those with a baseline 10-year ASCVD risk of <5%, 5% to 7.5%, 7.5% to 20%, and & GE;20%, respectively. Appropriate control of risk factors, including low-density lipoprotein cholesterol, blood pressure, body mass index, exercise habits, and smoking status, was associated with lower ASCVD event rates, whereas failure to control these risk factors resulted in higher ASCVD event rates. CONCLUSIONS:The temporal change in 10-year ASCVD risk over a period of 4 to 5 years reflects success or failure in controlling major cardiovascular risk factors and indicates the risk of future ASCVD events. The increment 10-year ASCVD risk/year can be used as an indicator of primary prevention and guide the application of preventive measures.
引用
收藏
页码:1697 / 1706
页数:10
相关论文
共 50 条
  • [41] COPD as a risk factor for Coronary Artery Disease (CAD): Overview of 10-year atherosclerotic cardiovascular disease (ASCVD) risk assessment
    Ilievska, D. Buklioska
    Minov, J.
    Kamchevska, N. Kochovska
    Mickovski, I.
    Hasan, T.
    Baloski, M.
    Neshovska, R.
    Minova, N. Nedeska
    Prgova-Veljanova, B.
    Doneva, D.
    Trajkovska, V.
    Simeonova, M.
    Bushev, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [42] Statins for primary prevention in people with a 10% 10-year cardiovascular risk: too much medicine too soon?
    Yerrakalva, Dharani
    Griffin, Simon J.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2017, 67 (654): : 40 - +
  • [43] Cardiovascular risk factors and aortic valve stenosis: towards 10-year absolute risk charts for primary prevention
    Kjeldsen, Emilie W.
    Thomassen, Jesper Q.
    Rasmussen, Katrine L.
    Nordestgaard, Borge G.
    Tybjaerg-Hansen, Anne
    Frikke-Schmidt, Ruth
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024,
  • [44] Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020
    Jacobs, Joshua A.
    Addo, Daniel K.
    Zheutlin, Alexander R.
    Derington, Catherine G.
    Essien, Utibe R.
    Navar, Ann Marie
    Hernandez, Inmaculada
    Lloyd-Jones, Donald M.
    King, Jordan B.
    Rao, Shreya
    Herrick, Jennifer S.
    Bress, Adam P.
    Pandey, Ambarish
    JAMA CARDIOLOGY, 2023, 8 (05) : 443 - 452
  • [45] A FEASIBILITY STUDY ON 10-YEAR CVD RISK ASSESSMENT AS A SECONDARY PREVENTION TOOL FOR CARDIOVASCULAR DISEASE
    Shi, R.
    Lan, Y.
    Yu, W.
    CARDIOLOGY, 2017, 137 : 231 - 231
  • [46] Perirenal fat thickness contributes to the estimated 10-year risk of cardiovascular disease and atherosclerotic cardiovascular disease in type 2 diabetes mellitus
    Wang, Wei
    Lv, Feng Yan
    Tu, Mei
    Guo, Xiu Li
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [47] Coronary Artery Calcium in Assessment of Atherosclerotic Cardiovascular Disease Risk and its Role in Primary Prevention
    Hisamatsu, Takashi
    Kinuta, Minako
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (10) : 1289 - 1302
  • [48] Risk scoring in primary prevention of atherosclerotic cardiovascular disease: Strengths and limitations
    De Backer, Guy G.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (14) : 1531 - 1533
  • [49] Chronic kidney disease and 10-year risk of cardiovascular death
    Holzmann, Martin J.
    Carlsson, Axel C.
    Hammar, Niklas
    Ivert, Torbjorn
    Walldius, Goran
    Jungner, Ingmar
    Wandell, Per
    Arnlov, Johan
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (11) : 1187 - 1194
  • [50] ESTIMATING THE REDUCTION IN 10-YEAR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK WITH STATIN THERAPY: A VOYAGER META-ANALYSIS
    Palmer, M.
    Nicholls, S. J.
    Lundman, P.
    Barter, P. J.
    Karlson, B. W.
    ATHEROSCLEROSIS, 2015, 241 (01) : E21 - E22